期刊文献+

Flt3L免疫扩增恒河猴外周血树突状细胞前体(pDC_1/pDC_2)的研究

Immune amplification of peripheral blood pDC_1 and pDC_2 in rhesus monkey by Flt3L
原文传递
导出
摘要 目的 探讨Flt3L对恒河猴外周血树突状细胞前体 (pDC1和pDC2 )的免疫扩增作用。方法 健康猴艾滋病毒SIV阴性的恒河猴每日给予rhFlt3L 10 0 μg/kg体重皮下注射 ,于第 11天在氯胺硐全麻下采集静脉血 ,用Ficoll Hypaque梯度离心法提取外周血单核细胞 ,利用与恒河猴有交叉反应的人单克隆抗体以及三色流式细胞仪分离 pDC1和 pDC2 ,并与未经Flt3L作用的 pDC1和pDC2 在数量和细胞表现型上进行对比。结果 经Flt3L扩增的恒河猴外周血 pDC1和 pDC2 数量分别增加 7倍和 4倍 ,且细胞表现型和形态不发生改变。结论 Flt3L对恒河猴外周血pDC1和pDC2 具有免疫扩增作用。 Objective To study the immune amplification of peripheral blood pDC 1 and pDC 2 in rhesus monkey by Flt3L.Methods rhFlt3L (100 μg/kg every day) were subcutaneously injected into healthy,SIV-negative rhesus monkeys (M.mulatta).After 11 days,all animals were anesthetized with Ketamine and peripheral blood samples were collected.Ficoll-Hypaque density method was used to separate the mononuclear cells of peripheral blood.pDC 1 and pDC 2 were isolated by rare-event cytometric flow analysis using human monoclonal antibodies cross reactive with rhesus monkey and compared with those not treated with rhFlt3L in quantity and phenotypes.Results Populations of pDC 1 and pDC 2 were increased 7 fold and 4 fold respectively by Flt3L administration with the stabilization in quantity and phenotypes.Conclusion Flt3L increased pDC 1 and pDC 2 of rhesus monkey peripheral blood.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2003年第11期1005-1006,共2页 Chinese Journal of Experimental Surgery
基金 黑龙江省自然科学基金资助项目(2002D0201) 哈尔滨市科学研究基金资助项目(2002AFXXJ059)
关键词 FLT3L 免疫扩增 恒河猴 外周血 树突状细胞前体 pDC1 pDC2 Rhesus monkey Flt3L DC Immune regulation
  • 相关文献

参考文献9

  • 1Rusten IS, Lyman SD, Veiby OP, et al. The Fit3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. Blood, 1996, 87: 1317-1325.
  • 2Hudak S, Hunte B, Culpepper J, et al. Fh3/Flk2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood, 1995, 85:2747-2755.
  • 3Freedman AR, Zhu H, Levine JD, et al. Generation of b,,man T lymphocytes from bone marrow CD34 + cells in vitro. Nat Med, 1996, 2:46-51.
  • 4Hunte BE, Hudak S, Campbell D, et al. Flk2/Flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol, 1996,156: 489-496.
  • 5Antonysamy MA, Thomson AW. Fit3 ligand (FL) and its influence on immune reactivity. Cytokine, 2000,12 : 87-100.
  • 6Shaw SG, Maung AA, Steptoe RJ, et al. Expansion of functional NK cells in nlultiple tissue compartments of mice treated with Flt3-1igand:implications for anti-cancer and antiviral therapy. J Immunol, 1998,161:2817-2824.
  • 7Antonysamy MA, Steptoe RJ, Khanna A, et al. Fit-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. J Immunol, 1998, 160:4106-4113.
  • 8Antonysamy MA, Thomson AW. Fit3 ligand (FL) and its influence on immune reactivity. Cytokine, 2000, 12: 87-100.
  • 9Siena S, Di Nicola M, Bregni M, et al. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp Hematol, 1995, 23 : 1463-1471.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部